The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

The new framework unveiled May 20 says new COVID-19 shots should go only to those ages 65 and up or with underlying medical conditions.

The FDA's decision involves changing the standard of evidence required for COVID-19 vaccine approval in the U.S.

The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...